CDCA7

gene product
FLJ14736, JPO1
This gene was identified as a c-Myc responsive gene, and behaves as a direct c-Myc target gene. Overexpression of this gene is found to enhance the transformation of lymphoblastoid cells, and it complements a transformation-defective Myc Box II mutant, suggesting its involvement in c-Myc-mediated cell transformation. Two alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
106 antibodies from 21 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Proteintech Group
1 antibody
Biorbyt
10 antibodies
Atlas Antibodies
1 antibody
Abnova Corporation
3 antibodies
antibodies-online
43 antibodies
Novus Biologicals
2 antibodies
Affinity Biosciences
1 antibody
NovoPro Bioscience Inc.
1 antibody
LifeSpan BioSciences, Inc.
10 antibodies
Invitrogen Antibodies
4 antibodies
GeneTex
1 antibody
Aviva Systems Biology
2 antibodies
OriGene
2 antibodies
Creative Diagnostics
2 antibodies
MyBioSource
2 antibodies
Boster Biological Technology
1 antibody
Abbexa
2 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Sigma-Aldrich
1 antibody
St John's Laboratory
1 antibody